The second pair of genes, POLR2F and SIRT6, when expressed at expression levels lower than the mean were significantly associated with a poorer outcome for HPV18+ cervical cancer patients, which was not observed in HPV16+ patients. The gene discussed is POLR2F; the disease is cervical carcinoma.